期刊
MOLECULES
卷 23, 期 6, 页码 -出版社
MDPI
DOI: 10.3390/molecules23061274
关键词
betaine; pulmonary arterial hypertension; inflammatory response
资金
- Ningxia Natural Science Fund Key Project [NZ17058]
- Ministry of Education Chunhui project Cooperative Research Project [Z2016048]
- Advanced Subject Construction Research Project of Hui Ethnic Medicine [XY201525]
- Ningxia Hui Autonomous Region Science and Technology Innovation Leader Training Project [KJT2017005]
- Ningxia Medical University Youth Backbone Talent Cultivation Selected Project
Background: Pulmonary arterial hypertension (PAH) is characterized by increased pulmonary vascular resistance, leading to right ventricular failure and death. Recent studies have suggested that chronic inflammatory processes are involved in the pathogenesis of PAH. Several studies have demonstrated that betaine possesses outstanding anti-inflammatory effects. However, whether betaine exerts protective effects on PAH by inhibiting inflammatory responses in the lungs needs to be explored. To test our hypothesis, we aimed to investigate the effects of betaine on monocrotaline-induced PAH in rats and attempted to further clarify the possible mechanisms. Methods: PAH was induced by monocrotaline (50 mg/kg) and oral administration of betaine (100, 200, and 400 mg/kg/day). The mean pulmonary arterial pressure, right ventricular systolic pressure, and right ventricle hypertrophy index were used to evaluate the development of PAH. Hematoxylin and eosin staining and Masson staining were performed to measure the extents of vascular remodeling and proliferation in fibrous tissue. Monocyte chemoattractant protein-1 (MCP-1) and endothelin-1 (ET-1) were also detected by immunohistochemical staining. Nuclear factor-kappa B (NF-kappa B), tumor necrosis factor alpha (TNF-alpha), and interleukin-1 beta (IL-1 beta) were assessed by Western blot. Results: This study showed that betaine improved the abnormalities in right ventricular systolic pressure, mean pulmonary arterial pressure, right ventricle hypertrophy index, and pulmonary arterial remodeling induced by monocrotaline compared with the PAH group. The levels of MCP-1 and ET-1 also decreased. Western blot indicated that the protein expression levels of NF-kappa B, TNF-alpha, and IL-1 beta significantly decreased (p < 0.01). Conclusion: Our study demonstrated that betaine attenuated PAH through its anti-inflammatory effects. Hence, the present data may offer novel targets and promising pharmacological perspectives for treating monocrotaline-induced PAH.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据